Close Menu
  • News
  • Medical
  • Technology
  • Nanomaterials
  • Research
  • Blog
    • Nasiol.com
  • Contact
    • Tech7685@gmail.com
What's Hot

Ultrathin resonators set new standard for efficient light manipulation

June 7, 2025

Naturally derived nanoparticles show promise against cardiovascular and kidney disease

June 6, 2025

Ballistic electrons chart a new course for next-gen terahertz devices

June 6, 2025
Facebook X (Twitter) Instagram
Nanotech – Nanomaterials | Medical | Research | News Stories Updated Daily Nanotech – Nanomaterials | Medical | Research | News Stories Updated Daily
  • News
  • Medical
  • Technology
  • Nanomaterials
  • Research
  • Blog
    • Nasiol.com
  • Contact
    • Tech7685@gmail.com
Facebook X (Twitter) Instagram
Nanotech – Nanomaterials | Medical | Research | News Stories Updated Daily Nanotech – Nanomaterials | Medical | Research | News Stories Updated Daily
Home»News»Designing nanoparticles for pregnancy-safe treatments
News

Designing nanoparticles for pregnancy-safe treatments

March 18, 2024No Comments4 Mins Read
Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email
Designing nanoparticles for pregnancy-safe treatments
Share
Facebook Twitter LinkedIn Pinterest Telegram Email
Ionizable lipid structure influences mRNA delivery in human placental trophoblasts in vitro. Credit: Proceedings of the National Academy of Sciences (2024). DOI: 10.1073/pnas.2307810121

Too often, the lack of clinical trials means that pregnant women suffer because available medications are prescribed off-label for them or not at all. A new study offers proof of concept for the important parameters to develop pregnancy-safe gene therapies.

The power of lipid nanoparticles (LNPs) is more broadly appreciated since the COVID-19 mRNA vaccines were distributed in hundreds of millions of people, including pregnant people. Researchers at Carnegie Mellon University are working to unlock all sorts of new therapies by treating disease at the gene level.

“In thinking about the future of genetic medicine, we would like to understand what could be good for pregnant people as well,” says Kathryn Whitehead.

Whitehead, professor of chemical engineering and biomedical engineering, is among the first to study mRNA delivery during pregnancy.

In a paper published in PNAS, Whitehead provides structural guidance on the design of lipid nanoparticles for safe use during pregnancy. Lipid nanoparticles are the delivery vehicles that bring mRNA into cells.

A lot of the questions surrounding gene therapies in pregnant versus non-pregnant people have to do with the delivery vehicle. It’s not clear if the same delivery vehicle can be used for all or if one needs to be specially developed for safe use during pregnancy.

Whitehead’s research provides insight as to how changes during pregnancy alter nanoparticle behavior compared to non-pregnant people.

The immune system, and its usual response to anything foreign, changes during pregnancy. It is important to understand changes in the immune response to lipid nanoparticles because of potential toxicities and other issues.

See also  Super-efficient laser light-induced detection of cancer cell-derived nanoparticles achieved

Whitehead’s study shows that lipid nanoparticle effects during pregnancy are chemistry-dependent. The inclusion of different lipids in the nanoparticle alters its chemistry, which in turn changes the way the immune system responds.

In the study, researchers looked at 260 different lipids. They included materials known to work well without causing much of an immune response, materials known to work well and to cause an immune response, and materials known to work poorly.

The study shows that the lipid nanoparticles used in the Whitehead lab do not cross into the fetus. During pregnancy, the body has different barriers to drug delivery. One of the most obvious is the placenta. It is key in providing nutrients to the fetus, while also inhibiting the transport of anything toxic. Most therapies that a woman would need should be kept out of the fetus. Whitehead’s research shows it is possible to deliver mRNA to the placenta without it accumulating in the fetus.

There are a number of diseases where there is dysfunction with the placenta. One of the most common is preeclampsia. “If we can deliver mRNA to the placenta, then it opens up opportunities for therapy and also to explore why these diseases are happening,” says Whitehead.

Researchers also looked at lipid nanoparticles that were shown to be inflammatory in previous research and found that they hindered fetal development. This confirms that delivering an inflammatory lipid nanoparticle during pregnancy is harmful in a quantitative and structurally-dependent way.

There are certain chemistries for which researchers can predict that anything containing that particular structural group will cause a problem. By better understanding structure-function, researchers can more accurately predict what lipids to use in the future.

See also  New synthesis technology for single-crystal 2D semiconductors could spawn next-generation devices

Collaborators at Magee-Womens Research Institute were instrumental in the early stages of the study. As the research progresses, Whitehead is connecting with new partners there.

Whitehead says this work on mRNA delivery during pregnancy will propel the design of new pregnancy-safe treatments. The findings might lead to better treatments for maternal disorders like preterm birth or preeclampsia, perhaps within the next decade.

Provided by
Carnegie Mellon University Chemical Engineering



Source link

designing nanoparticles pregnancysafe treatments
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Posts

Ultrathin resonators set new standard for efficient light manipulation

June 7, 2025

Naturally derived nanoparticles show promise against cardiovascular and kidney disease

June 6, 2025

Ballistic electrons chart a new course for next-gen terahertz devices

June 6, 2025

‘Stealthy’ lipid nanoparticles give mRNA vaccines a makeover

June 5, 2025

Single-layer waveguide display uses achromatic metagratings for more compact augmented reality eyewear

June 5, 2025

2D hybrid material integrates graphene and silica glass for next-generation electronics

June 4, 2025

Comments are closed.

Top Articles
Research

Flinders Researchers Achieve Chemical-Free Gold Nanoparticle Production

News

Researchers confirm thermal insights for tiny circuits

News

Analyzing Semiconductor Nanodevices Through Spectroscopy

Editors Picks

Ultrathin resonators set new standard for efficient light manipulation

June 7, 2025

Naturally derived nanoparticles show promise against cardiovascular and kidney disease

June 6, 2025

Ballistic electrons chart a new course for next-gen terahertz devices

June 6, 2025

‘Stealthy’ lipid nanoparticles give mRNA vaccines a makeover

June 5, 2025
About Us
About Us

Your go-to source for the latest nanotechnology breakthroughs. Explore innovations, applications, and implications shaping the future at the molecular level. Stay informed, embrace the nano-revolution.

We're accepting new partnerships right now.

Facebook X (Twitter) Instagram Pinterest
Our Picks

Enhancing Hydrogen Production with Nanoneedles

August 9, 2023

Utilizing Back-Gate Voltage Biases for 2D Materials

September 8, 2023

Nanoparticle-based delivery system could offer treatment for diabetics with rare insulin allergy

July 19, 2024

Subscribe to Updates

Get the latest creative Nano Tech news from Elnano.com

© 2025 Elnano.com - All rights reserved.
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.

Cleantalk Pixel